{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:19:11Z","timestamp":1791566351829,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RC2AG036613"],"award-info":[{"award-number":["RC2AG036613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.exger.2014.12.002","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T16:00:17Z","timestamp":1417622417000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story"],"prefix":"10.1016","volume":"68","author":[{"given":"Arlan","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Oddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2014.12.002_bb0005","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.2353\/ajpath.2010.091050","article-title":"Rapamycin extends maximal lifespan in cancer-prone mice","volume":"176","author":"Anisimov","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exger.2014.12.002_bb0010","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.4161\/cc.10.24.18486","article-title":"Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice","volume":"10","author":"Anisimov","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.exger.2014.12.002_bb0015","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.neurobiolaging.2011.06.002","article-title":"Dietary restriction but not rapamycin extends disease onset and survival of the H46R\/H48Q mouse model of ALS","volume":"33","author":"Bhattacharya","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exger.2014.12.002_bb0020","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1681\/ASN.2004030180","article-title":"Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy","volume":"16","author":"Bonegio","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.exger.2014.12.002_bb0025","doi-asserted-by":"crossref","first-page":"e57808","DOI":"10.1371\/journal.pone.0057808","article-title":"Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage","volume":"8","author":"Brewster","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2014.12.002_bb0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.exger.2014.12.002_bb0035","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exger.2014.12.002_bb0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0045","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1523\/JNEUROSCI.0777-14.2014","article-title":"Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer's disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature","volume":"34","author":"Caccamo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2014.12.002_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0378-1119(94)90141-4","article-title":"Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs","volume":"141","author":"Cafferkey","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.exger.2014.12.002_bb0055","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1016\/S0041-1345(03)00356-7","article-title":"The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation","volume":"35","author":"Camardo","year":"2003","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exger.2014.12.002_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/msb.2010.108","article-title":"A comprehensive map of the mTOR signaling network","volume":"6","author":"Caron","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.exger.2014.12.002_bb0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0092-8674(00)81653-0","article-title":"A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis","volume":"99","author":"Casadio","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.14573\/altex.1310071","article-title":"Animal models of Alzheimer disease: historical pitfalls and a path forward","volume":"31","author":"Cavanaugh","year":"2014","journal-title":"ALTEX"},{"key":"10.1016\/j.exger.2014.12.002_bb0075","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1476-5381.2008.00102.x","article-title":"Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels","volume":"156","author":"Chen","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exger.2014.12.002_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvm103","article-title":"Rapamycin modulates the eNOS vs. shear stress relationship","volume":"78","author":"Cheng","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.exger.2014.12.002_bb0085","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/aging.100496","article-title":"New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53\u2212\/\u2212 mice by delaying carcinogenesis","volume":"4","author":"Comas","year":"2012","journal-title":"Aging"},{"key":"10.1016\/j.exger.2014.12.002_bb0095","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1073\/pnas.2335979100","article-title":"Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells","volume":"100","author":"Dubois","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","article-title":"Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders","volume":"17","author":"Ehninger","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.exger.2014.12.002_bb0105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.exger.2014.12.002_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nbd.2006.12.003","article-title":"Rapamycin is a neuroprotective treatment for traumatic brain injury","volume":"26","author":"Erlich","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exger.2014.12.002_bb0115","doi-asserted-by":"crossref","first-page":"e83988","DOI":"10.1371\/journal.pone.0083988","article-title":"Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome","volume":"9","author":"Fok","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2014.12.002_bb0120","doi-asserted-by":"crossref","first-page":"13544","DOI":"10.1073\/pnas.0800041105","article-title":"Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice","volume":"105","author":"Fujishita","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuroscience.2012.06.054","article-title":"Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice","volume":"223","author":"Halloran","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.exger.2014.12.002_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1474-9726.2006.00267.x","article-title":"Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans","volume":"6","author":"Hansen","year":"2007","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exger.2014.12.002_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1940-6207.CAPR-13-0299","article-title":"eRapa restores a normal life span in a FAP mouse model","volume":"7","author":"Hasty","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.exger.2014.12.002_bb0145","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0150","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4161\/auto.4989","article-title":"Autophagy is required for dietary restriction-mediated life span extension in C. elegans","volume":"3","author":"Jia","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.exger.2014.12.002_bb0155","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.exger.2014.12.002_bb0160","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1115535","article-title":"Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients","volume":"310","author":"Kaeberlein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.exger.2014.12.002_bb0165","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","article-title":"Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway","volume":"14","author":"Kapahi","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.exger.2014.12.002_bb0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.18632\/aging.100573","article-title":"Rapamycin suppresses brain aging in senescence-accelerated OXYS rats","volume":"5","author":"Kolosova","year":"2013","journal-title":"Aging"},{"key":"10.1016\/j.exger.2014.12.002_bb0175","doi-asserted-by":"crossref","first-page":"709","DOI":"10.18632\/aging.100498","article-title":"Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+\/\u2212 mice","volume":"4","author":"Komarova","year":"2012","journal-title":"Aging"},{"key":"10.1016\/j.exger.2014.12.002_bb0180","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","article-title":"Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement","volume":"41","author":"Lang","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exger.2014.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.exger.2014.12.002_bb0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.18632\/aging.100533","article-title":"Rapamycin extends life span of Rb1+\/\u2212 mice by inhibiting neuroendocrine tumors","volume":"5","author":"Livi","year":"2013","journal-title":"Aging"},{"key":"10.1016\/j.exger.2014.12.002_bb0195","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2014.12.002_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0205","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2014.12.002_bb0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/gerona\/glq178","article-title":"Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice","volume":"66","author":"Miller","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2014.12.002_bb0215","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/acel.12194","article-title":"Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction","volume":"13","author":"Miller","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11523-011-0183-8","article-title":"Are we ready to move away from nature? The rapamycin story","volume":"6","author":"Mita","year":"2011","journal-title":"Target. Oncol."},{"key":"10.1016\/j.exger.2014.12.002_bb0225","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0002-9440(10)64839-0","article-title":"Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice","volume":"157","author":"Mucke","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exger.2014.12.002_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2007.09.019","article-title":"Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR\u2212\/\u2212 mice despite severe hypercholesterolemia","volume":"198","author":"Mueller","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.exger.2014.12.002_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0197-4580(00)00130-5","article-title":"Vascular and metabolic reserve in Alzheimer's disease","volume":"21","author":"Nagata","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exger.2014.12.002_bb0240","doi-asserted-by":"crossref","first-page":"20093","DOI":"10.1073\/pnas.1005554107","article-title":"Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders","volume":"107","author":"Neasta","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0245","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1172\/JCI67674","article-title":"Rapamycin extends murine lifespan but has limited effects on aging","volume":"123","author":"Neff","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exger.2014.12.002_bb0250","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2741\/s310","article-title":"The role of mTOR signaling in Alzheimer disease","volume":"4","author":"Oddo","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.exger.2014.12.002_bb0255","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.exger.2014.12.002_bb0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.fjc.0000177985.14305.15","article-title":"Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis","volume":"46","author":"Pakala","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.exger.2014.12.002_bb0265","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nn.2369","article-title":"Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling","volume":"12","author":"Puighermanal","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exger.2014.12.002_bb0270","doi-asserted-by":"crossref","first-page":"144ra103","DOI":"10.1126\/scitranslmed.3003802","article-title":"Rapamycin reverses elevated mTORC1 signaling in lamin A\/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival","volume":"4","author":"Ramos","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exger.2014.12.002_bb0275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.exger.2014.12.002_bb0280","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1172\/JCI70800","article-title":"Rapamycin, anti-aging, and avoiding the fate of Tithonus","volume":"123","author":"Richardson","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exger.2014.12.002_bb0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1073\/pnas.0710424105","article-title":"Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities","volume":"105","author":"Ruan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.exger.2014.12.002_bb0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11523-011-0168-7","article-title":"Aging and cancer: can mTOR inhibitors kill two birds with one drug?","volume":"6","author":"Sharp","year":"2011","journal-title":"Target. Oncol."},{"key":"10.1016\/j.exger.2014.12.002_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11523-011-0174-9","article-title":"Common toxicities of mammalian target of rapamycin inhibitors","volume":"6","author":"Soefje","year":"2011","journal-title":"Target. Oncol."},{"key":"10.1016\/j.exger.2014.12.002_bb0310","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2014.12.002_bb0315","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbagen.2009.06.007","article-title":"The TOR pathway comes of age","volume":"1790","author":"Stanfel","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exger.2014.12.002_bb0320","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-131124","article-title":"Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease","volume":"38","author":"Sun","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.exger.2014.12.002_bb0325","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1073\/pnas.012605299","article-title":"A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus","volume":"99","author":"Tang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exger.2014.12.002_bb0330","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4161\/auto.5.5.8504","article-title":"Rapamycin inhibits mTORC1, but not completely","volume":"5","author":"Thoreen","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.exger.2014.12.002_bb0335","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1460-9568.2003.02820.x","article-title":"Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory","volume":"18","author":"Tischmeyer","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exger.2014.12.002_bb0340","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature11310","article-title":"Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice","volume":"488","author":"Tsai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exger.2014.12.002_bb0345","first-page":"426,620","article-title":"Genetics: influence of TOR kinase on lifespan in C. elegans","author":"Vellai","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.exger.2014.12.002_bb0350","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.exger.2014.12.002_bb0355","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/auto.7.4.14541","article-title":"Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Zhang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.exger.2014.12.002_bb0360","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/gerona\/glt056","article-title":"Rapamycin extends life and health in C57BL\/6 mice","volume":"69","author":"Zhang","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2014.12.002_bb0365","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2012.12.033","article-title":"mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons","volume":"77","author":"Zhou","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.exger.2014.12.002_bb0370","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556514003490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556514003490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T23:44:13Z","timestamp":1566085453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556514003490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":74,"alternative-id":["S0531556514003490"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2014.12.002","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}